PolyPid Ltd. (PYPD)

Market Closed

30 Jul, 20:00

NASDAQ (CM)

4. 37

+0.29

+7.1078%

40.76M Market Cap

- P/E Ratio

- Div Yield

132,967 Volume

-3.89 Eps

$ 4.08

Previous Close

Investors:

Add Transaction

Day Range

4.13 4.41

Year Range

3.06 5.73

Want to track PYPD and more in your Portfolio? 🎯

Get Started For Free

PolyPid Q1 Earnings Call Highlights

PolyPid NASDAQ: PYPD said its first quarter marked a transition from late-stage clinical development toward regulatory submission and commercial preparation for D-PLEX100, its lead product candidate for preventing surgical site infections in abdominal colorectal surgery.

Marketbeat | 2 months ago

PolyPid Ltd. (PYPD) Q1 2026 Earnings Call Transcript

Seekingalpha | 2 months ago

PolyPid Ltd. (PYPD) Q4 2025 Earnings Call Transcript

Seekingalpha | 5 months ago

PolyPid Ltd. (PYPD) Discusses the Science and Business Case for D-PLEX100 in Tackling Surgical Site Infections Transcript

Seekingalpha | 7 months ago

PolyPid Ltd. (PYPD) Q2 2025 Earnings Call Transcript

PolyPid Ltd. (NASDAQ:PYPD ) Q2 2025 Earnings Conference Call August 13, 2025 8:30 AM ET Company Participants Dikla Czaczkes Akselbrad - CEO & Director Jonny Missulawin - Chief Financial Officer Ori Warshavsky - Chief Operating Officer—US Conference Call Participants Chase Richard Knickerbocker - Craig-Hallum Capital Group LLC, Research Division Douglas Royal Buchanan - Citizens JMP Securities, LLC, Research Division Yehuda Leibler - Unidentified Company Operator Greetings, and welcome to PolyPid's Second Quarter 2025 Conference Call.

Seekingalpha | 11 months ago

PolyPid Ltd. (PYPD) Q1 2025 Earnings Call Transcript

PolyPid Ltd. (NASDAQ:PYPD ) Q1 2025 Earnings Call May 14, 2025 8:30 AM ET Company Participants Brian Ritchie - Investor Relations Dikla Czaczkes Akselbrad - Chief Executive Officer Jonny Missulawin - Chief Financial Officer Ori Warshavsky - Chief Operating Officer, U.S. Conference Call Participants Roy Buchanan - JMP Securities Chase Knickerbocker - Craig-Hallum Bupalan Pachaiyappan - ROTH Capital Brian Ritchie Thank you all for participating in PolyPid's First Quarter 2025 Earnings Conference Call.

Seekingalpha | 1 year ago

PolyPid Ltd. (PYPD) Q4 2024 Earnings Call Transcript

PolyPid Ltd. (NASDAQ:PYPD ) Q4 2024 Results Conference Call February 12, 2025 8:30 AM ET Company Participants Brian Ritchie - Investor Relations, LifeSci Advisors Dikla Czaczkes Akselbrad - Chief Executive Officer Jonny Missulawin - Chief Financial Officer Ori Warshavsky - Chief Operating Officer, U.S. Conference Call Participants Roy Buchanan - JMP Chase Knickerbocker - Craig-Hallum Ram Selvaraju - H.C.

Seekingalpha | 1 year ago

PolyPid Ltd. (PYPD) Q3 2024 Earnings Call Transcript

PolyPid Ltd. (NASDAQ:PYPD ) Q3 2024 Earnings Conference Call November 13, 2024 8:30 AM ET Company Participants Brian Ritchie - Investor Relations, LifeSci Advisors Dikla Czaczkes Akselbrad - Chief Executive Officer Ori Warshavsky - Chief Operating Officer, U.S. Jonny Missulawin - Chief Financial Officer Conference Call Participants Roy Buchanan - JMP Chase Knickerbocker - Craig-Hallum Operator Greetings, and welcome to the PolyPid Third Quarter 2024 Conference Call.

Seekingalpha | 1 year ago

PolyPid Ltd (PYPD) Q2 2024 Earnings Call Transcript

PolyPid Ltd (NASDAQ:PYPD ) Q2 2024 Results Earnings Conference Call August 14, 2024 8:30 AM ET Company Participants Brian Ritchie - Investor Relations, LifeSci Advisors Dikla Czaczkes Akselbrad - Chief Executive Officer Ori Warshavsky - Chief Operating Officer, US Jonny Missulawin - Chief Financial Officer Conference Call Participants Roy Buchanan - JMP Securities Raghuram Selvaraju - H.C. Wainwright & Co. Operator Greetings and welcome to the PolyPid Second Quarter 2024 Conference Call.

Seekingalpha | 1 year ago

Blog Affiliate Program About Terms Privacy Help Contact Us